IL6 and COVID-19: Patients with ILD showed no significant elevation in cytokines (IL-6, TNF-α, and IFN-γ), inflammatory biomarkers, C-reactive protein, ferritin, or D-dimer (Figure 4A–F), indicating that patients with COVID-19 and ILD did not manifest additional hyperinflammation compared with the control individuals.